Company news

CSPC Pharmaceutical Group Limited news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

CSPC Pharmaceutical Group: Voluntary announcement - nbl-012 obtains clinical trial approval in china

April 23, 2021

Voluntary announcement - application for marketing approval of "duvelisib capsules" accepted by nmpa

April 19, 2021

CSPC Pharmaceutical Group: Proposals for general mandates to buy-back shares and to issue shares and mandate to grant options, re-election of the retiring directors, and notice of annual general meeting

April 14, 2021

Investigational new drug nbl-015 granted orphan-drug designation by the U.S. FDA

April 9, 2021

Voluntary announcement - "amphotericin b cholesteryl sulfate complex for injection" obtains drug registration approval

April 1, 2021

Voluntary announcement - first patient dosed in phase i clinical trial of "docetaxel for injection (albumin-bound)"

March 30, 2021

CSPC Pharmaceutical Group: Voluntary announcement - JMT601 obtains clinical trial approval in the U.S.

March 29, 2021

CSPC Pharmaceutical Group: Voluntary announcement - JMT601 obtains clinical trial approval in china

March 25, 2021

Annual results for the year ended 31 December 2020

March 15, 2021

Voluntary announcement - product licensing and commercialization agreement

March 9, 2021

Appointment and resignation of independent non-executive directors

March 5, 2021

INSIDE INFORMATION - PRINCIPAL FINANCIAL INFORMATION OF CSPC INNOVATION PHARMACEUTICAL CO., LTD. FOR THE YEAR ENDED 31 December 2020

March 4, 2021

Notice of extraordinary general meeting

September 22, 2020

← Newer news releases

Decks

The 5 newest of 17 decks. Every deck is listed under its year.